Application of medical gases in the field of neurobiology

Medical Gas Research

Volumn 1, Issue 1, 2011, Pages

  Liu, Wenwu ^a   Khatibi, Nikan ^b   Sridharan, Aishwarya ^b   Zhang, John H ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Gas pre conditioning; hydrogen therapy; Medical gases; oxygen therapy

Indexed keywords

ARGON; DRINKING WATER; HELIUM; HYDROGEN; OXYGEN; SEVOFLURANE; XENON;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASTHMA; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRONCHIOLITIS; CELL DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RESEARCH; DRUG SAFETY; DYSPNEA; ENCEPHALITIS; ENERGY METABOLISM; FLUID THERAPY; HEART PROTECTION; HEMODYNAMICS; HEPATITIS; HUMAN; HYPERBARIC OXYGEN; HYPEROXIA; HYPERVENTILATION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INTRACRANIAL HYPERTENSION; ISCHEMIC PRECONDITIONING; LIVER FIBROSIS; LUNG TOXICITY; MENTAL DETERIORATION; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROPHARMACOLOGY; NEUROPROTECTION; NEUROTOXICITY; NEWBORN HYPOXIA; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; OXYGEN CONSUMPTION; OXYGEN SUPPLY; OXYGEN THERAPY; OXYGEN TOXICITY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SCHISTOSOMIASIS; SPINAL CORD ISCHEMIA; SQUAMOUS CELL CARCINOMA; THERAPY EFFECT; TRANSIENT ISCHEMIC ATTACK; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; VOMITING;

EID: 84861501840     PISSN: None     EISSN: 20459912     Source Type: Journal    
DOI: 10.1186/2045-9912-1-13     Document Type: Review

References (209)

1. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation - a tale of three gases! Pharmacol Ther. Li L, Hsu A, Moore PK, 2009 123 3 386 400
2. The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Coburn M, Maze M, Franks NP, Crit Care Med 2008 36 2 588 95 10.1097/01.CCM.0B013E3181611F8A6 18216607 (Pubitemid 351158637)
3. Xenon: recent developments and future perspectives. Derwall M, Coburn M, Rex S, Hein M, Rossaint R, Fries M, Minerva Anestesiol 2009 75 1-2 37 45 18475253
4. Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia. David HN, Haelewyn B, Chazalviel L, Lecocq M, Degoulet M, Risso JJ, Abraini JH, J Cereb Blood Flow Metab 2009 29 6 1159 65 10.1038/jcbfm.2009.40 19384333
5. Cancer: looking outside the genome. Folkman J, Hahnfeldt P, Hlatky L, Nat Rev Mol Cell Biol 2000 1 1 76 9 10.1038/35036100 11413493
6. Why do cancers have high aerobic glycolysis? Gatenby RA, Gillies RJ, Nat Rev Cancer 2004 4 11 891 9 10.1038/nrc1478 15516961 (Pubitemid 39472955)
7. Hyperbaric-oxygen therapy. Tibbles PM, Edelsberg JS, N Engl J Med 1996 334 25 1642 8 10.1056/NEJM199606203342506 8628361 (Pubitemid 26192525)
8. Supplemental perioperative oxygen and the risk of surgical wound infection, a randomized controlled study. Belda J, Aguilera L, de la Asuncion JG, Alberti J, Vicente R, Fernandiz L, Rodriguez R, Company B, Sessler DI, Aguilar G, Botello SG, Orti R, J Am Med Assoc 2005 294 2035 2042 10.1001/jama.294.16.2035 (Pubitemid 41539936)
9. Physiologic effects of hyperbaric oxygen on microorganisms and host defences against infection. Mathieu D, Wattel F, Handbook on Hyperbaric Medicine Dordrecht, The Netherlands: Springer, Mathieu D, 2006 103 119
10. Effects of oxygen at high partial pressure. Lambertsen CJ, Handbook of Physiology: Respiration Bethesda, MD: American Physiological Society, Fenn WO, Rahn H, 1965 2 1027 1046 Section 3
11. Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Singhal AB, Dijkhuizen RM, Rosen BR, Lo EH, Neurology 2002 58 6 945 52 11914413 (Pubitemid 34242073)
12. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Singhal AB, Benner T, Roccatagliata L, Koroshetz WJ, Schaefer PW, Lo EH, Buonanno FS, Gonzalez RG, Sorensen AG, Stroke 2005 36 4 797 802 10.1161/01.STR.0000158914.66827.2e 15761201
13. The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. Kety SS, Schmidt CF, J Clin Invest 1948 27 4 484 92 10.1172/JCI101995 18873798
14. Effects of high atmospheric pressure and oxygen on middle cerebral blood flow velocity in humans measured by transcranial Doppler. Omae T, Ibayashi S, Kusuda K, Nakamura H, Yagi H, Fujishima M, Stroke 1998 29 1 94 7 10.1161/01.STR.29.1.94 9445335 (Pubitemid 28046948)
15. Cerebral oxygen vasoreactivity and cerebral tissue oxygen reactivity. Johnston AJ, Steiner LA, Gupta AK, Menon DK, Br J Anaesth 2003 90 6 774 86 10.1093/bja/aeg104 12765894 (Pubitemid 36700782)
16. Effects of hyperbaric oxygen therapy on cerebral oxygenation and mitochondrial function following moderate lateral fluid-percussion injury in rats. Daugherty WP, Levasseur JE, Sun D, Rockswold GL, Bullock MR, J Neurosurg 2004 101 3 499 504 10.3171/jns.2004.101.3.0499 15352608 (Pubitemid 39100727)
17. Effects of hyperbaric oxygenation therapy on cerebral metabolism and intracranial pressure in severely brain injured patients. Rockswold SB, Rockswold GL, Vargo JM, Erickson CA, Sutton RL, Bergman TA, Biros MH, J Neurosurg 2001 94 3 403 11 10.3171/jns.2001.94.3.0403 11235943 (Pubitemid 32786018)
18. A prospective, randomized clinical trial to compare the effect of hyperbaric to normobaric hyperoxia on cerebral metabolism, intracranial pressure, and oxygen toxicity in severe traumatic brain injury. Rockswold SB, Rockswold GL, Zaun DA, Zhang X, Cerra CE, Bergman TA, Liu J, J Neurosurg 2010 112 5 1080 94 10.3171/2009.7.JNS09363 19852540
19. Effect of hyperoxia on regional oxygenation and metabolism after severe traumatic brain injury: preliminary findings. Nortje J, Coles JP, Timofeev I, Fryer TD, Aigbirhio FI, Smielewski P, Outtrim JG, Chatfield DA, Pickard JD, Hutchinson PJ, Gupta AK, Menon DK, Crit Care Med 2008 36 1 273 81 10.1097/01.CCM.0000292014.60835.15 18090356
20. Hyperbaric oxygen treatment attenuated the decrease in regional glucose metabolism of rats subjected to focal cerebral ischemia: a high resolution positron emission tomography study. Lou M, Zhang H, Wang J, Wen SQ, Tang ZQ, Chen YZ, Yan WQ, Ding MP, Neuroscience 2007 146 2 555 61 10.1016/j.neuroscience. 2007.01.046 17367940 (Pubitemid 46617051)
21. Functional inhibition of rat polymorphonuclear leukocyte B2 integrins by hyperbaric oxygen is associated with impaired cGMP synthesis. Chen Q, Banick PD, Thom SR, J Pharmacol Exp Ther 1996 276 929 933 8786572
22. Effect of 100% oxygen on E-selectin expression, recruitment of neutrophils and enterocyte apoptosis following intestinal ischemia-reperfusion in a rat. Sukhotnik I, Coran AG, Greenblatt R, Brod V, Mogilner J, Shiloni E, Shaoul R, Bitterman H, Pediatr Surg Int 2008 24 1 29 35 10.1007/s00383-007-2039- y 17962962
23. Hyperbaric oxygen down-regulates ICAM-1 expression induced by hypoxia and hypoglycaemia: the role of eNOS. Buras JA, Stahl GL, Svoboda KS, Reenstra WR, Am J Physiol 2000 278 292 C302
24. Hyperbaric oxygen inhibits ischemia-reperfusion-induced neutrophil CD18 polarization by a nitric oxide mechanism. Jones SR, Carpin KM, Woodward SM, Khiabani KT, Stephenson LL, Wang WZ, Zamboni WA, Plast Reconstr Surg 2010 126 2 403 11 10.1097/PRS.0b013e3181df64a5 20679826
25. Endothelial-neutrophil interactions during ischemia and reperfusion injury: basic mechanisms of hyperbaric oxygen. Buras JA, Reenstra WR, Neurol Res 2007 29 2 127 31 10.1179/016164107X174147 17439696 (Pubitemid 46685265)
26. Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model. Yin W, Badr AE, Mychaskiw G, Zhang JH, Brain Res 2002 926 165 71 10.1016/S0006-8993(01)03304-2 11814419 (Pubitemid 34117602)
27. Oxygen-sensitive outcomes and gene expression in acute ischemic stroke. Rink C, Roy S, Khan M, Ananth P, Kuppusamy P, Sen CK, Khanna S, J Cereb Blood Flow Metab 2010 30 7 1275 87 10.1038/jcbfm.2010.7 20145654
28. Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. Yin D, Zhou C, Kusaka I, Calvert JW, Parent AD, Nanda A, Zhang JH, J Cereb Blood Flow Metab 2003 23 7 855 64 12843789 (Pubitemid 36818693)
29. Effect of hyperbaric oxygen on apoptosis in neonatal hypoxia-ischemia rat model. Calvert JW, Zhou C, Nanda A, Zhang JH, J Appl Physiol 2003 95 5 2072 80 14555671 (Pubitemid 37310393)
30. Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats. Henninger N, Bouley J, Nelligan JM, Sicard KM, Fisher M, J Cereb Blood Flow Metab 2007 27 9 1632 42 10.1038/sj.jcbfm.9600463 17311078 (Pubitemid 47301449)
31. Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Qin Z, Karabiyikoglu M, Hua Y, Silbergleit R, He Y, Keep RF, Xi G, Stroke 2007 38 4 1362 7 10.1161/01.STR. 0000259660.62865.eb 17322079 (Pubitemid 351664269)
32. Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Veltkamp R, Siebing DA, Sun L, Heiland S, Bieber K, Marti HH, Nagel S, Schwab S, Schwaninger M, Stroke 2005 36 8 1679 83 10.1161/01.STR.0000173408.94728.79 16020761 (Pubitemid 41098761)
33. Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia. Sun L, Zhou W, Mueller C, Sommer C, Heiland S, Bauer AT, Marti HH, Veltkamp R, J Cereb Blood Flow Metab 2010 30 9 1651 60 10.1038/jcbfm.2010.50 20424638
34. Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. Liu W, Hendren J, Qin XJ, Shen J, Liu KJ, J Neurochem 2009 108 3 811 20 10.1111/j.1471-4159.2008.05821.x 19187098
35. Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke. Liu W, Sood R, Chen Q, Sakoglu U, Hendren J, Cetin O, Miyake M, Liu KJ, J Neurochem 2008 107 5 1196 205 10.1111/j.1471-4159.2008.05664.x 18786175
36. Hyperbaric oxygen reduces tissue hypoxia and hypoxia-inducible factor-1 alpha expression in focal cerebral ischemia. Sun L, Marti HH, Veltkamp R, Stroke 2008 39 3 1000 6 10.1161/STROKEAHA.107.490599 18239183 (Pubitemid 351619543)
37. Matrix metalloproteinases and free radicals in cerebral ischemia. Liu JK, Rosenberg GA, Free Radic Biol Med 2005 39 1 71 80 10.1016/j.freeradbiomed.2005. 03.033 15925279 (Pubitemid 40733117)
38. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Rosenberg GA, Yang Y, Neurosurg Focus 2007 22 5 4 17613235
39. HBO suppresses Nogo-A, Ng-R, or RhoA expression in the cerebral cortex after global ischemia. Zhou C, Li Y, Nanda A, Zhang JH, Biochem Biophys Res Commun 2003 309 2 368 76 10.1016/j.bbrc.2003.08.006 12951059 (Pubitemid 37025901)
40. Hyperbaric hyperoxia and normobaric reoxygenation increase excitability and activate oxygen-induced potentiation in CA1 hippocampal neurons. Garcia AJ, Putnam RW, Dean JB, J Appl Physiol 2010 109 3 804 19 10.1152/japplphysiol.91429. 2008 20558753
41. [Influence of hyperbaric oxygen treatment on neural plasticity in experimental rats]. Ma MM, Zhang L, Liu BQ, [Article in Chinese] Zhong Nan Da Xue Xue Bao Yi Xue Ban 2008 33 12 1113 8 19141977
42. The effect of hyperventilation and hyperoxia on cerebral venous oxygen saturation in patients with traumatic brain injury. Thiagarajan A, Goverdhan PD, Chari P, Somasunderam K, Anesth Analg 1998 87 4 850 3 9768781 (Pubitemid 28455481)
43. Normobaric hyperoxia - induced improvement in cerebral metabolism and reduction in intracranial pressure in patients with severe head injury: a prospective historical cohort-matched study. Tolias CM, Reinert M, Seiler R, Gilman C, Scharf A, Bullock MR, J Neurosurg 2004 101 3 435 44 10.3171/jns.2004.101.3.0435 15537201 (Pubitemid 39100720)
44. Lack of improvement in cerebral metabolism after hyperoxia in severe head injury: a microdialysis study. Magnoni S, Ghisoni L, Locatelli M, Caimi M, Colombo A, Valeriani V, Stocchetti N, J Neurosurg 2003 98 5 952 8 10.3171/jns.2003.98.5.0952 12744353 (Pubitemid 36460884)
45. Effect of hyperoxia on cerebral metabolic rate for oxygen measured using positron emission tomography in patients with acute severe head injury. Diringer MN, Aiyagari V, Zazulia AR, Videen TO, Powers WJ, J Neurosurg 2007 106 4 526 9 10.3171/jns.2007.106.4.526 17432700 (Pubitemid 46536446)
46. Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. Singhal AB, Wang X, Sumii T, Mori T, Lo EH, J Cereb Blood Flow Metab 2002 22 7 861 8 12142571 (Pubitemid 34747603)
47. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Ronning OM, Guldvog B, Stroke 1999 30 10 2033 7 10.1161/01.STR.30.10.2033 10512903 (Pubitemid 29473245)
48. Magnetic resonance spectroscopy study of oxygen therapy in ischemic stroke. Singhal AB, Ratai E, Benner T, Vangel M, Lee V, Koroshetz WJ, Schaefer PW, Sorensen AG, Gonzalez RG, Stroke 2007 38 10 2851 4 10.1161/STROKEAHA.107. 487280 17761914 (Pubitemid 47494029)
49. Venturi mask adjuvant oxygen therapy in severe acute ischemic stroke. Chiu EH, Liu CS, Tan TY, Chang KC, Arch Neurol 2006 63 5 741 4 10.1001/archneur.63.5.741 16682544
50. Changes of plasma C-reactive protein in patients with craniocerebral injury before and after hyperbaric oxygenation: A randomly controlled study. Xie ZY, Zhuang MH, Lin L, Xu HW, Chen LX, Hu LN, Neural Regeneration Research 2007 2 5 314 7 (Pubitemid 47249256)
51. Glasgow Coma Scale, brain electric activity mapping and Glasgow Outcome Scale after hyperbaric oxygen treatment of severe brain injury. Ren H, Wang W, Ge Z, Chin J Traumatol 2001 4 4 239 41 11835741
52. Results of a prospective randomized trial for treatment of severely braininjured patients with hyperbaric oxygen. Rockswold GL, Ford SE, Anderson DC, Bergman TA, Sherman RE, J Neurosurg 1992 76 6 929 34 10.3171/jns.1992.76.6. 0929 1588426
53. Effect of hyperbaric oxygen on patients with traumatic brain injury. Lin JW, Tsai JT, Lee LM, Lin CM, Hung CC, Hung KS, Chen WY, Wei L, Ko CP, Su YK, Chiu WT, Acta Neurochir Suppl 2008 101 145 9 10.1007/978-3-211-78205-7/25 18642650
54. Hyperbaric oxygenation for the treatment of acute cerebral edema. Sukoff MH, Ragatz RE, Neurosurgery 1982 10 1 29 38 10.1227/00006123-198201000-00006 7057975 (Pubitemid 12212271)
55. Clinical application of hyperbaric oxygenation in the treatment of acute cerebral damage. Mogami H, Hayakawa T, Kanai N, Kuroda R, Yamada R, Ikeda T, Katsurada K, Sugimoto T, J Neurosurg 1969 31 6 636 43 10.3171/jns.1969.31.6.0636 5359209
56. Response of cerebrospinal fluid pressure to hyperbaric oxygenation. Hayakawa T, Kanai N, Kuroda R, Yamada R, Mogami H, J Neurol Neurosurg Psychiatry 1971 34 5 580 6 10.1136/jnnp.34.5.580 5122387
57. Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury. Bennett MH, Trytko B, Jonker B, Cochrane Database Syst Rev 2004 4 D004609
58. Hyperbaric oxygen therapy for traumatic brain injury: a systematic review of the evidence. McDonagh M, Helfand M, Carson S, Russman BS, Arch Phys Med Rehabil 2004 85 7 1198 204 10.1016/j.apmr.2003.12.026 15241774 (Pubitemid 38962384)
59. Current controversies in the management of patients with severe traumatic brain injury. Adamides AA, Winter CD, Lewis PM, Cooper DJ, Kossmann T, Rosenfeld JV, ANZ J Surg 2006 76 3 163 74 10.1111/j.1445-2197.2006.03674.x 16626360 (Pubitemid 43363022)
60. A review of the scientific evidence on the treatment of traumatic brain injuries and strokes with hyperbaric oxygen. Alternative Therapy Evaluation Committee for the Insurance Corporation of British Columbia, Brain Inj 2003 17 3 225 36 12623499
61. A study of the influence of high atmospheric pressure and hypothermia on dilution of the blood. Boerema I, Meyne NG, Brummelkamp WK, Bouma S, Mensch MH, Kamermans F, Sternhanf M, Van Aaldern W, Life without blood, J Cardiovasc Surg 1960 1 133 146
62. Effect of hyperbaric oxygen on experimental cerebral infarction in dog with preliminary correlations of cerebral blood flow at 2 atmospheres of oxygen. Jacobson I, Lawson DD, J Neurosurg 1963 20 849 59 10.3171/jns.1963.20.10.0849 14186080
63. Hyperbaric oxygenation alleviates MCAO-induced brain injury and reduces hydroxyl radical formation and glutamate release. Yang ZJ, Xie Y, Bosco GM, Chen C, Camporesi EM, Eur J Appl Physiol 2010 108 3 513 22 10.1007/s00421-009-1229-9 19851780
64. Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats. Michalski D, Küppers-Tiedt L, Weise C, Laignel F, Härtig W, Raviolo M, Schneider D, Hobohm C, Brain Res 2009 1303 161 8 19766603
65. The effect of oxygen therapy on brain damage and cerebral pO 2in transient focal cerebral ischemia in the rat. Hou H, Grinberg O, Williams B, Grinberg S, Yu H, Alvarenga DL, Wallach H, Buckey J, Swartz HM, Physiol Meas 2007 28 8 963 76 10.1088/0967-3334/28/8/017 17664686 (Pubitemid 47421728)
66. Hyperbaric oxygen induces rapid protection against focal cerebral ischemia. Veltkamp R, Siebing DA, Heiland S, Schoenffeldt-Varas P, Veltkamp C, Schwaninger M, Schwab S, Brain Res 2005 1037 1-2 134 8 10.1016/j.brainres.2005. 01.006 15777761 (Pubitemid 40362389)
67. Delayed and multiple hyperbaric oxygen treatments expand therapeutic window in rat focal cerebral ischemic model. Yin D, Zhang JH, Neurocrit Care 2005 2 2 206 11 10.1385/NCC:2:2:206 16159067 (Pubitemid 41270868)
68. [Effect of hyperbaric oxygenation on the clinical course and complications of the acute period of ischemic strokes]. Lebedev VV, Isakov Iu V, Pravdenkova SV, Zh Vopr Neirokhir Im N N Burdenko 1983 3 37 42 (Pubitemid 13038757)
69. [Hyperbaric oxygenation and prevention of recurrent cerebral circulatory disorders in the acute stage of a stroke]. Pravdenkova SV, Romasenko MV, Shelkovskii VN, Zh Nevropatol Psikhiatr Im S S Korsakova 1984 84 8 1147 51 6495936
70. Verbesserte reversibilitat des traumatischen mittelhirnsyndroms bei Anwendung der hyperbaren oxygenierung. Holbach KH, Wassman H, Kolberg T, Acta Neurochir 1974 30 247 56 10.1007/BF01405583
71. [Stroke therapy. Combined therapy of hyperbaric oxygenation and extra-intracranial arterial bypass operation]. Wassmann H, Fortschr Med 1982 100 7 285 8 7076096 (Pubitemid 12083109)
72. A pilot study of hyperbaric oxygen in the treatment of human stroke. Anderson DC, Bottini AG, Jagiella WM, Westphal B, Ford S, Rockswold GL, Loewenson RB, Stroke 1991 22 9 1137 42 10.1161/01.STR.22.9.1137 1926256
73. Hyperbaric oxygen in the treatment of acute ischemic stroke. Nighoghossian N, Trouillas P, Adeleine P, Salord F, A double-blind pilot study. Stroke 1995 26 8 1369 72
74. Hyperbaric oxygen therapy in acute ischemic stroke: Results of the hyperbaric oxygen in acute ischemic stroke trial pilot study. Rusyniak DE, Kirk MA, May JD, Kao LW, Brizendine EJ, Welch JL, Cordell WH, Alonso RJ, Hyperbaric oxygen therapy in acute ischemic stroke, Stroke 2003 34 2 571 4 10.1161/01.STR.0000050644.48393.D0 12574578 (Pubitemid 36206367)
75. Hyperbaric oxygen therapy for acute ischemic stroke. Bennett MH, Wasiak J, Schnabel A, Kranke P, French C, Cochrane Database Syst Rev 2005 3 D004954
76. Prolonged anoxic survival due to anoxia pre-exposure: brain ATP, lactate, and pyruvate. Dahl NA, Balfour WM, Am J Physiol 1964 207 452 6 14205366
77. Adaptation of adult brain tissue to anoxia and hypoxia in vitro. Schurr A, Reid KH, Tseng MT, West C, Rigor BM, Brain Res 1986 374 2 244 8 10.1016/0006-8993(86)90418-X 3719335 (Pubitemid 16077975)
78. Intermittent brief periods of ischemia have a cumulative effect and may cause myocardial necrosis. Geft IL, Fishbein MC, Ninomiya K, Hashida J, Chaux E, Yano J, Y-Rit J, Genov T, Shell W, Ganz W, Circulation 1982 66 6 1150 3 10.1161/01.CIR.66.6.1150 7139894 (Pubitemid 13238826)
79. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Murry CE, Jennings RB, Reimer KA, Circulation Circulation 1986 74 5 1124 36 (Pubitemid 17174962)
80. 'Ischemic tolerance' phenomenon detected in various brain regions. Kitagawa K, Matsumoto M, Kuwabara K, Tagaya M, Ohtsuki T, Hata R, Ueda H, Handa N, Kimura K, Kamada T, Brain Res 1991 561 2 203 11 10.1016/0006-8993(91)91596-S 1802339
81. Heart protection by ischemic preconditioning: a novel pathway initiated by iron and mediated by ferritin. Chevion M, Leibowitz S, Aye NN, Novogrodsky O, Singer A, Avizemer O, Bulvik B, Konijn AM, Berenshtein E, J Mol Cell Cardiol 2008 45 6 839 45 10.1016/j.yjmcc.2008.08.011 18817783
82. Possible involvement of ubiquitin proteasome system and other proteases in acute and delayed aspects of ischemic preconditioning of brain in mice. Rehni AK, Singh TG, Behl N, Arora S, Biol Pharm Bull 2010 33 12 1953 7 10.1248/bpb.33.1953 21139232
83. Protective effect of ischemic postconditioning on lung ischemia-reperfusion injury in rats and the role of heme oxygenase-1. Xia ZY, Gao J, Ancharaz AK, Chin J Traumatol 2009 12 3 162 6 19486559
84. The role of Tregs and CD11c(+) macrophages/dendritic cells ischemic preconditioning of the kidney. Cho WY, Choi HM, Lee SY, Kim MG, Kim HK, Jo SK, Kidney Int 2010 78 10 981 92 10.1038/ki.2010.266 20686446
85. Delayed ischemic preconditioning protects against liver ischemia-reperfusion injury in vivo. Romanque P, Díaz A, Tapia G, Uribe-Echevarría S, Videla LA, Fernandez V, Transplant Proc 2010 42 5 1569 75 10.1016/j.transproceed.2009.11.052 20620476
86. Paraquat-induced neutrophil alveolitis: reduction of the inflammatory response by pretreatment with endotoxin and hyperoxia. Martin WJ, Howard DM, Lung 1986 164 2 107 20 3084880 (Pubitemid 16165916)
87. Hyperoxia prevents hypoxia-induced bronchial hyperreactivity via a cyclooxygenase-independent mechanism. D'Brot J, Ahmed T, J Appl Physiol 1991 70 2 740 7 1902458
88. Repeated hyperbaric oxygen induces ischemic tolerance in gerbil hippocampus. Wada K, Ito M, Miyazawa T, Katoh H, Nawashro H, Shima K, Chigasaki H, Brain Res 1996 740 1-2 15 20 18 10.1016/S0006-8993(96)00831-1 8973793 (Pubitemid 26411278)
89. Hyperbaric oxygen preconditioning activates ribosomal protein S6 kinases and reduces brain swelling after intracerebral hemorrhage. Qin Z, Hua Y, Liu W, Silbergleit R, He Y, Keep RF, Hoff JT, Xi G, Acta Neurochir Suppl 2008 102 317 20 10.1007/978-3-211-85578-2/60 19388337
90. The effect of hyperbaric oxygen preconditioning on heat shock protein 72 expression following in vitro stress in human monocytes. Vince RV, Midgley AW, Laden G, Madden LA, Cell Stress Chaperones 2011 16 3 339 43 10.1007/s12192-010- 0246-2 21132545
91. Preconditioning with prolonged oxygen exposure induces ischemic tolerance in the brain via oxygen free radical formation. Zhang X, Xiong L, Hu W, Zheng Y, Zhu Z, Liu Y, Chen S, Wang X, Can J Anaesth 2004 51 3 258 63 10.1007/BF03019107 15010410 (Pubitemid 39010956)
92. Pretreatment with oxygen protects rat kidney from cisplatin nephrotoxicity. Rasoulian B, Jafari M, Mahbod M, Dehaj ME, Nowrozi M, Wahhabaghai H, Mofid M, Ghasemi A, Bigdeli MR, Khoshbaten A, Ren Fail 2010 32 2 234 42 10.3109/08860221003592838 20199186
93. Hyperbaric oxygen preconditioning induces tolerance against brain ischemia-reperfusion injury by upregulation of antioxidant enzymes in rats. Li J, Liu W, Ding S, Xu W, Guan Y, Zhang JH, Sun X, Brain Res 2008 1210 223 9 18407255
94. Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. Nie H, Xiong L, Lao N, Chen S, Xu N, Zhu Z, J Cereb Blood Flow Metab 2006 26 5 666 74 10.1038/sj.jcbfm.9600221 16136055
95. Effect of preconditioned hyperbaric oxygen and ozone on ischemia-reperfusion induced tourniquet in skeletal bone of rats. Koca K, Yurttas Y, Bilgic S, Cayci T, Topal T, Durusu M, Kaldirim U, Akgul EO, Ozkan H, Yanmis I, Oguz E, Tunay S, Korkmaz A, Basbozkurt M, J Surg Res 2010 164 1 83 9 10.1016/j.jss.2010.06.030 20850777
96. Hyperoxia-induced protection against rat's renal ischemic damage: relation to oxygen exposure time. Wahhabaghai H, Rasoulian B, Esmaili M, Mehrani HA, Mohammadhosseniakbari H, Mofid M, Jafari M, Noroozi M, Foadoddini M, Asgai A, Khoshbaten A, Ren Fail 2009 31 6 514 21 10.1080/08860220902963863 19839829
97. Preconditioning with prolonged normobaric hyperoxia induces ischemic tolerance partly by upregulation of antioxidant enzymes in rat brain tissue. Bigdeli MR, Brain Res 2009 1260 47 54 19167368
98. In vivo normobaric hyperoxia preconditioning induces different degrees of antioxidant enzymes activities in rat brain tissue. Bigdeli MR, Rasoulian B, Meratan AA, Eur J Pharmacol 2009 611 1-3 22 9 10.1016/j.ejphar.2009.03.034 19303405
99. Up-regulated HIF-1alpha is involved in the hypoxic tolerance induced by hyperbaric oxygen preconditioning. Peng Z, Ren P, Kang Z, Du J, Lian Q, Liu Y, Zhang JH, Sun X, Brain Res 2008 1212 71 8 18439571
100. Mechanism of ischemic tolerance induced by hyperbaric oxygen preconditioning involves upregulation of hypoxia-inducible factor-1 and erythropoietin in rats. Gu GJ, Li YP, Peng ZY, Xu JJ, Kang ZM, Xu WG, Tao HY, Ostrowski RP, Zhang JH, Sun XJ, J Appl Physiol 2008 104 4 1185 91 10.1152/japplphysiol.00323.2007 18174394 (Pubitemid 351507961)
101. Hyperbaric oxygen preconditioning promotes angiogenesis in rat liver after partial hepatectomy. Ren P, Kang Z, Gu G, Liu Y, Xu W, Tao H, Zhang JH, Sun X, Ji H, Life Sci 2008 83 7-8 236 41 10.1016/j.lfs.2008.06.011 18644387
102. Cyclo-oxygenase-2 mediates hyperbaric oxygen preconditioning-induced neuroprotection in the mouse model of surgical brain injury. Jadhav V, Ostrowski RP, Tong W, Matus B, Jesunathadas R, Zhang JH, Stroke 2009 40 9 3139 42 10.1161/STROKEAHA.109.549774 19628811
103. Cyclooxygenase-2 Mediates Hyperbaric Oxygen Preconditioning in the Rat Model of Transient Global Cerebral Ischemia. Cheng O, Ostrowski RP, Wu B, Liu W, Chen C, Zhang JH, Stroke 2011 42 2 484 90 10.1161/STROKEAHA.110.604421 21164135
104. Repetitive hyperbaric oxygen exposures enhance sensitivity to convulsion by upregulation of eNOS and nNOS. Liu W, Li J, Sun X, Liu K, Zhang JH, Xu W, Tao H, Brain Res 2008 1201 128 34 18342297
105. Reduced matrix metalloproteinase-9 activity and cell death after global ischemia in the brain preconditioned with hyperbaric oxygen. Ostrowski RP, Jadhav V, Chen W, Zhang JH, Acta Neurochir Suppl 2010 106 47 9 10.1007/978-3-211-98811-4/7 19812919
106. The hyperbaric oxygen preconditioning-induced brain protection is mediated by a reduction of early apoptosis after transient global cerebral ischemia. Ostrowski RP, Graupner G, Titova E, Zhang J, Chiu J, Dach N, Corleone D, Tang J, Zhang JH, Neurobiol Dis 2008 29 1 1 13 10.1016/j.nbd.2007.07.020 17822911 (Pubitemid 350180478)
107. Repeated preconditioning with hyperbaric oxygen induces neuroprotection against forebrain ischemia via suppression of p38 mitogen activated protein kinase. Yamashita S, Hirata T, Mizukami Y, Cui YJ, Fukuda S, Ishida K, Matsumoto M, Sakabe T, Brain Res 2009 1301 171 9 19747454
108. Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases. Ruusalepp A, Czibik G, Flatebø T, Vaage J, Valen G, Basic Res Cardiol 2007 102 4 318 26 10.1007/s00395-007-0644-5 17268885 (Pubitemid 46909710)
109. Brain derived neurotrophic factor activation of Trk B induces vascular endothelial growth factor expression via hypoxia inducible factor-1 in neuroblastoma cells. Nakamura K, Martin KC, Jackson JK, Beppu K, Woo CW, Thiele CJ, Cancer Res 2006 66 8 4249 55 10.1158/0008-5472.CAN-05-2789 16618748
110. Hyperbaric oxygen preconditioning reduces ischemia-reperfusion injury by inhibition of apoptosis via mitochondrial pathway in rat brain. Li JS, Zhang W, Kang ZM, Ding SJ, Liu WW, Zhang JH, Guan YT, Sun XJ, Neuroscience 2009 159 4 1309 15 10.1016/j.neuroscience.2009.01.011 19185051
111. Mechanism of hyperbaric oxygen preconditioning in neonatal hypoxia-ischemia rat model. Li Z, Liu W, Kang Z, Lv S, Han C, Yun L, Sun X, Zhang JH, Brain Res 2008 1196 151 6 18221732
112. In vivo hyperoxic preconditioning protects against rat-heart ischemia/reperfusion injury by inhibiting mitochondrial permeability transition pore opening and cytochrome c release. Petrosillo G, Di Venosa N, Moro N, Colantuono G, Paradies V, Tiravanti E, Federici A, Ruggiero FM, Paradies G, Free Radic Biol Med 2011 50 3 477 83 10.1016/j.freeradbiomed.2010.11.030 21130864
113. Preconditioning with sublethal ischemia or intermittent normobaric hyperoxia up-regulates glutamate transporters and tumor necrosis factor-alpha converting enzyme in the rat brain. Bigdeli MR, Rahnema M, Khoshbaten A, J Stroke Cerebrovasc Dis 2009 18 5 336 42 10.1016/j.jstrokecerebrovasdis.2008.12. 005 19717015
114. Hyperoxia confers myocardial protection in mechanically ventilated rats through the generation of free radicals and opening of mitochondrial ATP-sensitive potassium channels. Colantuono G, Tiravanti EA, Di Venosa N, Cazzato A, Rastaldo R, Cagiano R, D'Agostino D, Federici A, Fiore T, Clin Exp Pharmacol Physiol 2008 35 1 64 71 10.1111/j.1440-1681.2007.04745.x 18047630 (Pubitemid 350197684)
115. Role of tumor necrosis factor alpha and its receptor I in preconditioning by hyperoxia. Labruto F, Yang J, Vaage J, Valen G, Basic Res Cardiol 2005 100 3 198 207 10.1007/s00395-004-0509-0 15614439 (Pubitemid 41348810)
116. Hyperoxia elicits myocardial protection through a nuclear factor kappaB-dependent mechanism in the rat heart. Tähepld P, Vaage J, Starkopf J, Valen G, J Thorac Cardiovasc Surg 2003 125 3 650 60 10.1067/mtc.2003.36 12658209 (Pubitemid 36373913)
117. The temporal profile of genomic responses and protein synthesis in ischemic tolerance of the rat brain induced by repeated hyperbaric oxygen. Hirata T, Cui YJ, Funakoshi T, Mizukami Y, Ishikawa Y, Shibasaki F, Matsumoto M, Sakabe T, Brain Res 2007 1130 1 214 22 17173873 (Pubitemid 46053888)
118. Hyperbaric oxygen preconditioning attenuates early apoptosis after spinal cord ischemia in rats. Wang L, Li W, Kang Z, Liu Y, Deng X, Tao H, Xu W, Li R, Sun X, Zhang JH, J Neurotrauma 2009 26 1 55 66 10.1089/neu.2008.0538 19196076
119. Oxygen toxicity. Jenkinsons S, New Horizons 1993 1 4 504 11 8087571
120. Incidence of oxygen toxicity events during the treatment of dysbarism. Smerz R, Undersea Hyperb Med 2004 31 2 199 202 15485081 (Pubitemid 39225038)
121. Oxygen toxicity in premature infants. Weinberger B, Laskin DL, Heck DE, Laskin JD, Toxicol Appl Pharmacol 2002 181 1 60 7 10.1006/taap.2002.9387 12030843 (Pubitemid 34615412)
122. Failure of juice or juice extract from the noni plant (Morinda citrifolia) to protect rats against oxygen toxicity. Berg JT, Furusawa E, Hawaii Med J 2007 66 2 41 4 17393917
123. Heliox, nitrox, and trimix diving; hyperbaric oxygen treatment; and a flaw in Henry's law. Arieli R, J Appl Physiol 2007 102 4 1323 17409289 (Pubitemid 46571095)
124. Effect of heliox, oxygen and air breathing on helium bubbles after heliox diving. Hyldegaard O, Jensen T, Undersea Hyperb Med 2007 34 2 107 22 17520862
125. Use of helium as a new therapeutic gas. Barach AL, Proc Soc Exp Bio Med 1934 32 462 4
126. The therapeutic use of helium. Barach AL, JAMA 1935 107 1273 80
127. The utility of albuterol nebulized with heliox during acute asthma exacerbations. Kress JP, Noth I, Gehlbach BK, Barman N, Pohlman AS, Miller A, Morgan S, Hall JB, Am J Respir Crit Care Med 2002 165 9 1317 21 10.1164/rccm.9907035 11991886 (Pubitemid 34461747)
128. Heliox therapy in infants with acute bronchiolitis. Martinán- Torres F, Rodríguez-Nú̃ez A, Martinán-Sánchez JM, Pediatrics 2002 109 1 68 73 10.1542/peds.109.1.68 11773543 (Pubitemid 34049428)
129. Helium-hyperoxia: a novel intervention to improve the benefits of pulmonary rehabilitation for patients with COPD. Eves ND, Sandmeyer LC, Wong EY, Jones LW, MacDonald GF, Ford GT, Petersen SR, Bibeau MD, Jones RL, Chest 2009 135 3 609 18 10.1378/chest.08-1517 19017883
130. Inhaled heliumoxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children. Kudukis TM, Manthous CA, Schmidt GA, Hall JB, Wylam ME, J Pediatr 1997 130 2 217 24 10.1016/S0022- 3476(97)70346-9 9042123 (Pubitemid 27495156)
131. Gases in gases, liquids and their mixtures. Data extract from Landolt-Börnstein IV/15A, Chapter 4.1.1: Diffusion in Binary Gaseous Mixtures. Landolt-Börnstein-Group IV Physical Chemistry. Winkelmann J, Springer Berlin Heidelberg 2007 15A 1615 2018
132. Effect of oxygen and helium mixtures on ventricular fibrillation. Pifarré R, Raghunath TK, Vanecko RM, Chua FS, Balis JU, Neville WE, J Thorac Cardiovasc Surg 1970 60 5 648 52 5475216
133. Helium inhalation enhances vasodilator effect of inhaled nitric oxide on pulmonary vessels in hypoxic dogs. Nie M, Kobayashi H, Sugawara M, Tomita T, Ohara K, Yoshimura H, Am J Physiol: Heart Circ Physiol 2001 280 4 1875 81
134. Effect of breathing of a helium-oxygen mixture on the adaptation of the organism to exercise. Debiski W, Kossowski M, Gembicka D, Acta Physiol Pol 1984 35 3 285 92 6537722 (Pubitemid 15060586)
135. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D, Warltier DC, Pratt PF Jr, Anesth Analg 2007 105 3 562 9 10.1213/01.ane.0000278083.31991.36 17717207 (Pubitemid 47300827)
136. Helium-induced preconditioning in young and old rat heart: impact of mitochondrial Ca2+-sensitive potassium channel activation. Heinen A, Huhn R, Smeele KM, Zuurbier CJ, Schlack W, Preckel B, Weber NC, Hollmann MW, Anesthesiology 2008 109 5 830 6 10.1097/ALN.0b013e3181895aa0 18946295
137. Reactive oxygen species and mitochondrial adenosine triphosphate- regulated potassium channels mediate helium-induced preconditioning against myocardial infarction in vivo. Pagel PS, Krolikowski JG, Pratt PF Jr, Shim YH, Amour J, Warltier DC, Weihrauch D, J Cardiothorac Vasc Anesth 2008 22 4 554 9 10.1053/j.jvca.2008.04.005 18662630
138. The mechanism of helium-induced preconditioning: a direct role for nitric oxide in rabbits. Pagel PS, Krolikowski JG, Pratt PF Jr, Shim YH, Amour J, Warltier DC, Weihrauch D, Anesth Analg 2008 107 3 762 8 10.1213/ane. 0b013e3181815995 18713880
139. Inhibition of glycogen synthase kinase or the apoptotic protein p53 lowers the threshold of helium cardioprotection in vivo: the role of mitochondrial permeability transition. Pagel PS, Krolikowski JG, Pratt PF Jr, Shim YH, Amour J, Warltier DC, Weihrauch D, Anesth Analg 2008 107 3 769 75 10.1213/ane.0b013e3181815b84 18713881
140. Morphine reduces the threshold of helium preconditioning against myocardial infarction: the role of opioid receptors in rabbits. Pagel PS, Krolikowski JG, Amour J, Warltier DC, Weihrauch D, J Cardiothorac Vasc Anesth 2009 23 5 619 24 10.1053/j.jvca.2008.12.020 19231239
141. Helium breathing provides modest anti-inflammatory, but no endothelial protection against ischemia-reperfusion injury in humans in vivo. Lucchinetti E, Wacker J, Maurer C, Keel M, Härter L, Zaugg K, Zaugg M, Anesth Analg 2009 109 1 101 8 10.1213/ane.0b013e3181a27e4b 19535699
142. Heliox and oxygen reduce infarct volume in a rat model of focal ischemia. Pan Y, Zhang H, VanDeripe DR, Cruz-Flores S, Panneton WM, Exp Neurol 2007 205 2 587 90 10.1016/j.expneurol.2007.03.023 17467695 (Pubitemid 46755778)
143. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M, Ma D, Neurosci Lett 2009 460 3 232 6 10.1016/j.neulet.2009.05.069 19500647
144. Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells. Rizvi M, Jawad N, Li Y, Vizcaychipi MP, Maze M, Ma D, Exp Biol Med (Maywood) 2010 235 7 886 91 10.1258/ebm.2010.009366
145. How does xenon produce anaesthesia? Nature. Franks NP, Dickinson R, De Sousa SL, Hall AC, Lieb WR, 1998 396 324
146. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia. Banks P, Franks NP, Dickinson R, Anesthesiology 2010 112 3 614 22 10.1097/ALN. 0b013e3181cea398 20124979
147. Determinants of the sensitivity of AMPA receptors to xenon. Plested AJR, Wildman SS, Lieb WR, Franks NP, Anesthesiology 2004 100 2 347 58 10.1097/00000542-200402000-00025 14739810 (Pubitemid 38133703)
148. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels: Comparison with isoflurane and ethanol. Yamakura T, Harris RA, Anesthesiology 2000 93 4 1095 101 10.1097/00000542-200010000-00034 11020766
149. The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine 3 receptors expressed in Xenopus oocytes. Suzuki T, Koyama H, Sugimoto M, Uchida I, Masimo T, Anesthesiology 2002 96 3 699 704 10.1097/00000542-200203000-00028 11873047 (Pubitemid 34193512)
150. Noble gas xenon is a novel adenosine triphosphate-sensitive potassium channel opener. Bantel C, Maze M, Trapp S, Anesthesiology 2010 112 3 623 30 10.1097/ALN.0b013e3181cf894a 20179498
151. Two-poredomain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP, Mol Pharmacol 2004 65 443 52 10.1124/mol.65.2.443 14742687 (Pubitemid 38134273)
152. Effects of xenon on acetylcholine release in the rat cerebral cortex in vivo. Shichino T, Murakawa M, Adachi T, Miyazaki Y, Segawa H, Fukuda K, Mori K, Br J Anaesth 2002 88 6 866 8 10.1093/bja/88.6.866 12173207 (Pubitemid 34618965)
153. Does xenon anesthesia inhibit cholinesterase? An in vitro radiometric assessment. Ishiguro Y, Kikuchi T, Etsuki H, Niimi Y, Goto T, Morita S, Irie T, Anesthesiology 2003 98 3 791 2 10.1097/00000542-200303000-00034 12606930 (Pubitemid 36262613)
154. Differential nitric oxide synthase activity, cofactor availability and cGMP accumulation in the central nervous system during anaesthesia. Galley HF, Le Cras AE, Logan SD, Webster NR, Br J Anaesth 2001 86 3 388 94 10.1093/bja/86.3.388 11573530 (Pubitemid 32219953)
155. Effects of xenon on intracellular Ca2+ release in human endothelial cells. Petzelt C, Ose's-Prieto J, Klett FF, Schmehl W, Kox WJ, Exp Biol Online 1997 2 3 9
156. Halothane, isoflurane, xenon, and nitrous oxide inhibit calcium ATPase pump activity in rat brain synaptic plasma membranes. Franks JJ, Horn J-L, Janicki PK, Singh G, Anesthesiology 1995 82 1 108 17 10.1097/00000542-199501000- 00015 7832292
157. Effects of xenon anesthesia on cerebral blood flow in humans: a positron emission tomography study. Laitio RM, Kaisti KK, Låangsjö JW, Aalto S, Salmi E, Maksimow A, Aantaa R, Oikonen V, Sipilä H, Parkkola R, Scheinin H, Anesthesiology 2007 106 6 1128 33 10.1097/01.anes.0000267596.57497.92 17525587 (Pubitemid 46828165)
158. Positron emission tomography study of regional cerebral metabolism during general anesthesia with xenon in humans. Rex S, Schaefer W, Meyer PH, Rossaint R, Boy C, Setani K, Büll U, Baumert JH, Anesthesiology 2006 105 5 936 43 10.1097/00000542-200611000-00014 17065887 (Pubitemid 44655504)
159. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC- and p38 MAPK. Weber NC, Toma O, Wolter JI, Obal D, Mullenheim J, Preckel B, Schlack W, Br J Pharmacol 2005 144 1 123 32 15644876 (Pubitemid 40188554)
160. Upstream signaling of protein kinase C- in xenon-induced pharmacological preconditioning. Implication of mitochondrial adenosine triphosphate dependent potassium channels and phosphatidylinositol-dependent kinase-1. Weber NC, Toma O, Damla H, Wolter JI, Schlack W, Preckel B, Eur J Pharmacol 2006 539 1-2 1 9 10.1016/j.ejphar.2006.03.054 16716295 (Pubitemid 44208811)
161. Mechanisms of xenon-and isoflurane-induced preconditioning-a potential link to the cytoskeleton via the MAPKAPK-2/HSP27 pathway. Weber NC, Toma O, Wolter JI, Wirthle NM, Schlack W, Preckel B, Br J Pharmacol 2005 146 3 445 55 10.1038/sj.bjp.0706324 16086037 (Pubitemid 41486687)
162. Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo. Weber NC, Stursberg J, Wirthle NM, Toma O, Schlack W, Preckel B, Br J Anaesth 2006 97 3 298 306 10.1093/bja/ael153 16793779 (Pubitemid 44295664)
163. Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats. Mio Y, Shim YH, Richards E, Bosnjak ZJ, Pagel PS, Bienengraeber M, Anesth Analg 2009 108 3 858 66 10.1213/ane.0b013e318192a520 19224794
164. Xenon mitigates isoflurane-induced neuronal apoptosis in the developing rodent brain. Ma D, Williamson P, Januszewski A, Nogaro MC, Hossain M, Ong LP, Shu Y, Franks NP, Maze M, Anesthesiology 2007 106 4 746 53 10.1097/01.anes. 0000264762.48920.80 17413912 (Pubitemid 46555618)
165. Xenon pretreatment attenuates anesthetic-induced apoptosis in the developing brain in comparison with nitrous oxide and hypoxia. Shu Y, Patel SM, Pac-Soo C, Fidalgo AR, Wan Y, Maze M, Ma D, Anesthesiology 2010 113 2 360 8 10.1097/ALN.0b013e3181d960d7 20613483
166. Xenon modulates neutrophil adhesion molecule expression in vitro. de Rossi LW, Horn NA, Stevanovic A, Buhre W, Hutschenreuter G, Rossaint R, Eur J Anaesthesiol 2004 21 2 139 43 14977346 (Pubitemid 38176156)
167. Xenon induces late cardiac preconditioning in vivo: a role for cyclooxygenase 2? Weber NC, Frässdorf J, Ratajczak C, Grueber Y, Schlack W, Hollmann MW, Preckel B, Anesth Analg 2008 107 6 1807 13 10.1213/ane. Ob013e31818874bf 19020121
168. Xenon. No stranger to anaesthesia. Sanders RD, Franks NP, Maze M, Br J Anaesth 2003 91 5 709 17 10.1093/bja/aeg232 14570795 (Pubitemid 37369533)
169. Neuroprotective and neurotoxic properties of the inert gas xenon. Ma D, Wilhelm S, Maze M, Franks NP, Br J Anaesth 2002 89 5 739 46 12393773 (Pubitemid 35277224)
170. Effects of xenon on in vitro and in vivo models of neuronal injury. Wilhelm S, Ma D, Maze M, Franks NP, Anesthesiology 2002 96 6 1485 91 10.1097/00000542-200206000-00031 12170064 (Pubitemid 34587220)
171. Prevention of neurotoxicity in hypoxic cortical neurons by the noble gas xenon. Petzelt C, Blom P, Schmehl W, Müller J, Kox WJ, Life Sci 2003 72 17 1909 18 10.1016/S0024-3205(02)02439-6 12597990 (Pubitemid 36207528)
172. Xenon prevents cellular damage in differentiated PC-12 cells exposed to hypoxia. Petzelt C, Blom P, Schmehl W, Müller J, Kox WJ, BMC Neurosci 2004 5 55 10.1186/1471-2202-5-55 15588278 (Pubitemid 40177026)
173. The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Homi HM, Yokoo N, Ma D, Warner DS, Franks NP, Maze M, Grocott HP, Anesthesiology 2003 99 4 876 81 10.1097/00000542-200310000-00020 14508320 (Pubitemid 37186078)
174. Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Dingley J, Tooley J, Porter H, Thoresen M, Stroke 2006 37 2 501 6 10.1161/01.STR.0000198867.31134.ac 16373643 (Pubitemid 43732014)
175. Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia. David HN, Haelewyn B, Rouillon C, Lecoq M, Chazalviel L, Apiou G, Risso JJ, Lemaire M, Abraini JH, FASEB J 2008 22 4 1275 86 18024836 (Pubitemid 351519980)
176. Morphological evidence that xenon neuroprotects against N-methyl-DL-aspartic acid-induced damage in the rat arcuate nucleus: a time-dependent study. Natale G, Cattano D, Abramo A, Forfori F, Fulceri F, Fornai F, Paparelli A, Giunta F, Ann N Y Acad Sci 2006 1074 650 8 10.1196/annals.1369.063 17105960 (Pubitemid 44532867)
177. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ma D, Hossain M, Chow A, Arshad M, Battson RM, Sanders RD, Mehmet H, Edwards AD, Franks NP, Maze M, Ann Neurol 2005 58 2 182 93 10.1002/ana.20547 16049939 (Pubitemid 41098876)
178. Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models. Rajakumaraswamy N, Ma D, Hossain M, Sanders RD, Franks NP, Maze M, Neurosci Lett 2006 409 2 128 33 10.1016/j.neulet.2006.09.020 17052852 (Pubitemid 44634964)
179. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. Ma D, Hossain M, Pettet GK, Luo Y, Lim T, Akimov S, Sanders RD, Franks NP, Maze M, J Cereb Blood Flow Metab 2006 26 2 199 208 10.1038/sj.jcbfm.9600184 16034370 (Pubitemid 43151576)
180. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Luo Y, Ma D, Ieong E, Sanders RD, Yu B, Hossain M, Maze M, Anesthesiology 2008 109 5 782 9 10.1097/ALN.0b013e3181895f88 18946288
181. Production, metabolism, and excretion of hydrogen in the large intestine. Christl SU, Murgatroyd PR, Gibson GR, Cummings JH, Gastroenterology 1992 102 4 Pt 1 1269 77 1551534
182. Colonic hydrogen absorption: quantification of its effect on hydrogen accumulation caused by bacterial fermentation of carbohydrates. Hammer HF, Gut 1993 34 6 818 22 10.1136/gut.34.6.818 8314516 (Pubitemid 23185111)
183. Use of molecular hydrogen as an energy substrate by human pathogenic bacteria. Maier RJ, Biochem Soc Trans 2005 33 Pt 1 83 5 15667272 (Pubitemid 40313767)
184. Hydrogen and methane breath tests for evaluation of resistant carbohydrates. Rumessen JJ, Eur J Clin Nutr 1992 46 Suppl 2 77 90 1330532
185. Hydrogen breath test for diagnosis of lactose malabsorption: the importance of timing and the number of breath samples. Di Camillo M, Marinaro V, Argnani F, Foglietta T, Vernia P, Can J Gastroenterol 2006 20 4 265 268 16609755
186. The inulin hydrogen breath test accurately reflects orocaecal transit time. Schneider AR, Jepp K, Murczynski L, Biniek U, Stein J, Eur J Clin Invest 2007 37 10 802 7 10.1111/j.1365-2362.2007.01862.x 17727672 (Pubitemid 47480849)
187. Hyperbaric hydrogen therapy: a possible treatment for cancer. Dole M, Wilson FR, Fife WP, Science 1975 190 4210 152 4 10.1126/science.1166304 1166304
188. Hydrogen gas is not oxidized by mammalian tissues under hyperbaric conditions. Kayar SR, Axley MJ, Homer LD, Harabin AL, Undersea Hyperb Med 1994 21 3 265 75 7950800
189. Anti-inflammatory properties of molecular hydrogen: investigation on parasite-induced liver inflammation. Gharib B, Hanna S, Abdallahi OM, Lepidi H, Gardette B, De Reggi M, C R Acad Sci III 2001 324 8 719 24 11510417 (Pubitemid 32707449)
190. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S, Nat Med 2007 13 6 688 94 10.1038/nm1577 17486089 (Pubitemid 46889750)
191. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, Kitawaki J, Imai S, Nakano K, Ohta M, Adachi T, Obayashi H, Yoshikawa T, Nutr Res 2008 28 3 137 43 10.1016/j.nutres.2008.01.008 19083400 (Pubitemid 351452069)
192. Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release. Xie K, Yu Y, Pei Y, Hou L, Chen S, Xiong L, Wang G, Shock 2010 34 1 90 7 19997046
193. Hydrogen-rich saline protects myocardium against ischemia/reperfusion injury in rats. Sun Q, Kang Z, Cai J, Liu W, Liu Y, Zhang JH, Denoble PJ, Tao H, Sun X, Exp Biol Med (Maywood) 2009 234 10 1212 9 10.3181/0812-RM-349
194. Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Cai J, Kang Z, Liu WW, Luo X, Qiang S, Zhang JH, Ohta S, Sun X, Xu W, Tao H, Li R, Neurosci Lett 2008 441 167 172 10.1016/j.neulet.2008.05.077 18603371
195. Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Cai J, Kang Z, Liu K, Liu W, Li R, Zhang JH, Luo X, Sun X, Brain Res 2009 1256 129 137 19063869
196. Hydrogen gas is ineffective in moderate and severe neonatal hypoxia-ischemia rat models. Matchett GA, Fathali N, Hasegawa Y, Jadhav V, Ostrowski RP, Martin RD, Dorotta IR, Sun X, Zhang JH, Brain Res 2009 1259 90 97 19168038
197. Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Sato Y, Kajiyama S, Amano A, Kondo Y, Sasaki T, Handa S, Takahashi R, Fukui M, Hasegawa G, Nakamura N, Fujinawa H, Mori T, Ohta M, Obayashi H, Maruyama N, Ishigami A, Biochem Biophys Res Commun 2008 375 346 350 10.1016/j.bbrc.2008.08.020 18706888
198. Hydrogen rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress. Li J, Wang C, Zhang JH, Cai JM, Cao YP, Sun XJ, Brain Res 2010 1328 152 61 20171955
199. Hydrogen gas reduced acute hyperglycemia-enhanced hemorrhagic transformation in a focal ischemia rat model. Chen CH, Manaenko A, Zhan Y, Liu WW, Ostrowki RP, Tang J, Zhang JH, Neuroscience 2010 169 1 402 14 10.1016/j.neuroscience.2010.04.043 20423721
200. Consumption of molecular hydrogen prevents the stress-induced impairments in hippocampus-dependent learning tasks during chronic physical restraint in mice. Nagata K, Nakashima-Kamimura N, Mikami T, Ohsawa I, Ohta S, Neuropsychopharmacol 2009 34 501 508 10.1038/npp.2008.95
201. Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Fujita K, Seike T, Yutsudo N, Ohno M, Yamada H, Yamaguchi H, Sakumi K, Yamakawa Y, Kido MA, Takaki A, Katafuchi T, Tanaka Y, Nakabeppu Y, Noda M, PLoS One 2009 4 7247 10.1371/journal.pone.0007247 19789628
202. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease. Fu Y, Ito M, Fujita Y, Ichihara M, Masuda A, Suzuki Y, Maesawa S, Kajita Y, Hirayama M, Ohsawa I, Ohta S, Ohno K, Neurosci Lett 2009 453 2 81 5 10.1016/j.neulet.2009. 02.016 19356598
203. Drinking hydrogen water ameliorated cognitive impairment in senescence-accelerated mice. Gu Y, Huang CS, Inoue T, Yamashita T, Ishida T, Kang KM, Nakao A, J Clin Biochem Nutr 2010 46 3 269 76 10.3164/jcbn.10-19 20490324
204. Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Ryang YM, Fahlenkamp AV, Rossaint R, Wesp D, Loetscher PD, Beyer C, Coburn M, Crit Care Med 2011
205. Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Loetscher PD, Rossaint J, Rossaint R, Weis J, Fries M, Fahlenkamp A, Ryang YM, Grottke O, Coburn M, Crit Care 2009 13 6 206 10.1186/cc8214 20017934
206. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M, Ma D, Neurosci Lett 2009 460 3 232 6 10.1016/j.neulet.2009.05.069 19500647
207. Xenon preconditioning confers neuroprotection regardless of gender in a mouse model of transient middle cerebral artery occlusion. Limatola V, Ward P, Cattano D, Gu J, Giunta F, Maze M, Ma D, Neuroscience 2010 165 3 874 81 10.1016/j.neuroscience.2009.10.063 19895874
208. Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels. Bantel C, Maze M, Trapp S, Anesthesiology 2009 110 5 986 95 10.1097/ALN. 0b013e31819dadc7 19352153
209. Hydrogen is neuroprotective and preserves cerebrovascular reactivity in asphyxiated newborn pigs. Domoki F, Oláh O, Zimmermann A, Németh I, Táth-Szuki V, Hugyecz M, Temesvári P, Bari F, Pediatr Res 2010 68 5 387 92 20657346